Indo Us Bio-Tech Stock Screener | Share Price & Fundamental Analysis
INDOUS
Agricultural Products
Share Price NSE
₹106.29
▼
-0.26 (-0.24%)
Share Price BSE
₹106.61
▼
-0.57 (-0.53%)
As of April 13, 2026, the Indo Us Bio-Tech share price (NSE: INDOUS) is ₹106.29 on NSE and ₹106.61 on BSE, down 0.24% from the previous close, with shares trading between ₹103.00 and ₹107.17, and a 52-week range of ₹97.87–₹197.97.
Browse Indo Us Bio-Tech financial data to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Indo Us Bio-Tech Market Cap
₹213.13 Cr.
INDOUS P/E Ratio (TTM)
-
Indo Us Bio-Tech P/B Ratio
4.82
EPS (TTM)
₹8.27
Dividend Yield
-
Debt to Equity
0.41
INDOUS 52 Week High
₹197.97
Indo Us Bio-Tech 52 Week Low
₹97.87
Operating Margin
-
Profit Margin
-
INDOUS Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹56.00
Total Equity
₹39.00
Indo Us Bio-Tech Share Price History - Stock Screener Chart
Screen INDOUS historical share price movements with interactive charts. Analyze price trends and patterns.
Indo Us Bio-Tech Company Profile - Fundamental Screener
Screen Indo Us Bio-Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDOUS shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE250Z01010
Indo Us Bio-Tech Balance Sheet Screener
Screen INDOUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2022 | 2021 | 2020 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 44 | 35 |
| Current Assets | 47 | 38 | 32 |
| Fixed Assets | 6 | 2 | 1 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 5 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 39 | 21 | 16 |
| Share Capital | 9 | 6 | 6 |
| Reserves & Surplus | 29 | 15 | 10 |
Indo Us Bio-Tech Income Statement Screener - Profit & Revenue Analysis
Screen Indo Us Bio-Tech income statement and profit fundamentals.
Analyze INDOUS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Indo Us Bio-Tech share price evaluation.
| Item | None-None | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|
| Revenue | 0 | 50 | 40 | 40 |
| Expenses | 0 | 43 | 35 | 36 |
| EBITDA | 0 | 7 | 5 | 4 |
| Operating Profit % | 0.00% | 14.00% | 13.00% | 10.00% |
| Depreciation | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 5 | 4 | 3 |
| Tax | 0 | 0 | -1 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| EPS | 0.00 | 8.27 | 8.07 | 4.18 |
Indo Us Bio-Tech Cash Flow Screener - Liquidity Fundamentals
Screen INDOUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2022-March | 2021-March | 2020-March |
|---|---|---|---|
| Operating Activities | 3 | 0 | -1 |
| Investing Activities | -5 | -2 | -1 |
| Financing Activities | 3 | 2 | 2 |
| Net Cash Flow | 0 | 0 | 0 |
Indo Us Bio-Tech Shareholding Pattern Screener
See Indo Us Bio-Tech shareholding pattern with promoter, FII, and DII holdings.
Check Indo Us Bio-Tech promoter holding and ownership changes for INDOUS on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.29% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% |
| FII Holding | 0.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.46% | 24.34% | 24.36% | 24.14% | 23.69% | 24.43% | 24.42% | 23.98% |
| Other Holding | 7.07% | 5.49% | 5.47% | 5.69% | 6.13% | 5.40% | 5.40% | 5.85% |
| Shareholder Count | 4,531 | 2,780 | 3,112 | 4,130 | 4,738 | 1,183 | 1,133 | 838 |
Indo Us Bio-Tech Share Dividend Screener - Share Yield Analysis
Check Indo Us Bio-Tech dividend history with payout and yield data.
View Indo Us Bio-Tech dividend details including ex-dates and amounts for INDOUS stock.
Indo Us Bio-Tech Stock Index Membership
See which indices include Indo Us Bio-Tech stock.
Check INDOUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Indo Us Bio-Tech Market Events Screener - Corporate Actions
Get Indo Us Bio-Tech corporate actions including splits, bonuses, and buybacks.
Check Indo Us Bio-Tech stock events that may affect INDOUS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -8.69% | ||
| Annual General Meeting | NA | 3.60% | ||
| Annual General Meeting | NA | -11.18% | ||
| 2026-01-21 | 2026-01-21 | Quarterly Result Announcement | NA | -5.30% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.79% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -3.16% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -0.39% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -1.51% |
| 2024-12-03 | 2024-12-03 | Dividend | ₹ 0.25 /share | 22.71% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.20% |
| 2023-08-29 | 2023-08-29 | Bonus | 1:1 | 37.96% |
| 2021-11-29 | Bonus | 1:5 | - | |
| 2021-10-28 | 2021-10-29 | Dividend | ₹ 0.25 /share | -7.95% |
| 2018-01-11 | 2018-01-11 | Change Of Name | NA | - |
Indo Us Bio-Tech Competitors Screener - Peer Comparison
Screen INDOUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 14,109 | 21.91 | 8,770 | 12.12% | 612 | 56.39 |
| KRBL | 7,442 | 11.74 | 5,655 | 3.17% | 476 | 54.41 |
| Gujarat Ambuja Exports | 7,104 | 34.67 | 4,695 | -7.42% | 249 | 69.25 |
| Kaveri Seed Company | 4,759 | 15.82 | 1,251 | 3.28% | 282 | 68.89 |
| Trualt Bioenergy | 3,512 | 24.25 | 1,969 | 53.77% | 147 | 52.66 |
| GRM Overseas | 3,080 | 47.73 | 1,374 | 2.17% | 61 | 65.99 |
| Sanstar | 1,531 | 22.87 | 1,082 | -10.58% | 67 | 54.75 |
| Chaman Lal Setia Exports | 1,329 | 13.34 | 1,504 | 10.16% | 103 | 59.48 |
| Bombay Super Hybrid Seeds | 1,062 | 39.08 | 362 | 40.17% | 26 | 60.10 |
| Gulshan Polyols | 1,061 | 24.98 | 2,025 | 45.63% | 25 | 64.02 |
Indo Us Bio-Tech Company Announcements - News Screener
Screen INDOUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-03-11 | Announcement Under Regulation 30 (LODR)- Clarification On Price Movement | - |
| 2026-03-10 | Clarification sought from Indo Us Bio-Tech Ltd | - |
| 2026-03-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-21 | Results- Financial Results For December 31 2025 | - |
| 2026-01-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On 21St January 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-01-12 | Board Meeting Intimation for Consider Approve And Take On Record The Un-Audited Financial Results Of The Company Along With The Limited Review Reports For The Quarter And Nine Months Ended December 31 2025; | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Closure of Trading Window | - |
| 2025-12-29 | Disclosure under Regulation 30A of LODR | - |
| 2025-11-17 | Indo US Biotech Limited Is Proud To Announce Its Participation In The APSA Seed Congress 2025 Taking Place In Mumbai From 17Th To 20Th November 2025. | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-14 | Results-Financial Results For September 30 2025 | - |